Nonresponse to neoadjuvant chemotherapy for muscle-invasive urothelial cell carcinoma of the bladder

Clinical Genitourinary Cancer

Volumn 12, Issue 3, 2014, Pages 210-213

  Mossanen, Matthew ^a   Lee, Franklin ^a   Cheng, Heather ^a   Harris, William ^a   Shenoi, Jaideep ^b   Zhao, Song ^a   Wang, Junfeng ^c   Champion, Thomas ^a   Izard, Jason ^a   Gore, John L ^a   Porter, Michael P ^a   Yu, Evan Y ^a   Wright, Jonathan L ^a,d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Group Health   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Cisplatin; Cystectomy; Muscle invasive; Nonresponse; Urothelial cell cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOXORUBICIN; GEMCITABINE; METHOTREXATE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CYSTECTOMY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; MUSCLE INVASIVE BLADDER CANCER; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; TREATMENT RESPONSE; TUMOR BIOPSY; ADJUVANT THERAPY; CARCINOMA, TRANSITIONAL CELL; DRUG RESISTANCE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; SECONDARY; SURVIVAL; TUMOR INVASION; URINARY BLADDER NEOPLASMS;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; CYSTECTOMY; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 84900310180     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2013.10.002     Document Type: Article

References (24)

1. Advanced Bladder Cancer Meta-analysis Collaboration Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis Lancet 361 2003 1927 1934
2. J.J. Meeks, J. Bellmunt, and B.H. Bochner et al. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer Eur Urol 62 2012 523 533
3. D. Tilki, R.S. Svatek, and G. Novara et al. Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients J Urol 184 2010 888 894
4. H.B. Grossman, R.B. Natale, and C.M. Tangen et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 2003 859 866
5. G.S. Palapattu, S.F. Shariat, and P.I. Karakiewicz et al. Cancer specific outcomes in patients with pT0 disease following radical cystectomy J Urol 175 2006 1645 1649 discussion 1649
6. D. Pectasides, M. Pectasides, and M. Nikolaou Adjuvant and neoadjuvant chemotherapy in muscle invasive bladder cancer: literature review Eur Urol 48 2005 60 67 discussion 67-8
7. J.A. Martinez-Pineiro, M. Gonzalez Martin, and F. Arocena et al. Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: a prospective randomized phase III study J Urol 153 3 Pt 2 1995 964 973
8. D.M. Wallace, D. Raghavan, and K.A. Kelly et al. Neo-adjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder Br J Urol 67 1991 608 615
9. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists Lancet 354 1999 533 540
10. P.U. Malmstrom, E. Rintala, and R. Wahlqvist et al. Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group J Urol 155 1996 1903 1906
11. A. Sherif, E. Rintala, and O. Mestad et al. Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer - Nordic cystectomy trial 2 Scand J Urol Nephrol 36 2002 419 425
12. L. Sengelov, H. von der Maase, and F. Lundbeck et al. Neoadjuvant chemotherapy with cisplatin and methotrexate in patients with muscle-invasive bladder tumours Acta Oncol 41 2002 447 456
13. H.I. Scher Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomized clinical trials. Advanced bladder cancer overview collaboration J Urol 154 5 1995 1970
14. H. von der Maase, S.W. Hansen, and J.T. Roberts et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study J Clin Oncol 18 2000 3068 3077
15. J.T. Roberts, H. von der Maase, and L. Sengelov et al. Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer Ann Oncol 17 Suppl 5 2006 118 122
16. A. Dash, J.A. Pettus, and H.W. Herr et al. A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience Cancer 113 2008 2471 2477
17. O. Yeshchina, G.M. Badalato, and M.S. Wosnitzer et al. Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, Adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder Urol 79 2012 384 390
18. R. Petrioli, B. Frediani, and A. Manganelli et al. Comparison between a cisplatin-containing regimen and a carboplatin-containing regimen for recurrent or metastatic bladder cancer patients. A randomized phase II study Cancer 77 2 Jan 15 1996 344 351
19. J. Bellmunt, V. Guillem, and L. Paz-Ares et al. Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group J Clin Oncol 18 2000 3247 3255
20. L. Dogliotti, G. Carteni, and S. Siena et al. Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: results of a randomized phase 2 trial Eur Urol 52 2007 134 141
21. P. Turker, P.J. Bostrom, and M.L. Wroclawski et al. Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome BJU Int 110 2012 804 811
22. S. McLaughlin, J. Shephard, and E. Wallen et al. Comparison of the clinical and pathologic staging in patients undergoing radical cystectomy for bladder cancer Int Braz J Urol 33 2007 25 31 discussion 31-2
23. S.F. Shariat, G.S. Palapattu, and P.I. Karakiewicz et al. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy Eur Urol 51 2007 137 149 discussion 149-151
24. L. Cheng, R.M. Neumann, and A.L. Weaver et al. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens Am J Clin Pathol 113 2000 275 279